Tenax Therapeutics annual operating margin
2011
2012
2013
2014
2015
Tenax Therapeutics Operating Margin Growth & History (TENX)
Tenax Therapeutics's operating margin was −30,062.78% for fiscal 2015.
View full Tenax Therapeutics company overviewTenax Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2015 | 2015-04-30 | −30,062.78% | −19610.67 pp |
| 2014 | 2014-04-30 | −10,452.11% | −10016.40 pp |
| 2013 | 2013-04-30 | −435.71% | +1823.94 pp |
| 2012 | 2012-04-30 | −2,259.66% | −12498.08 pp |
| 2011 | 2011-04-30 | 10,238.43% | — |
Tenax Therapeutics quarterly operating margin
Q2.11
Q3.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q3 2014 | 2014-01-31 | −5,807.85% | −5092.21 pp |
| Q2 2014 | 2013-10-31 | −3,795.33% | −3662.70 pp |
| Q1 2014 | 2013-07-31 | −958.73% | −342.97 pp |
| Q4 2013 | 2013-04-30 | −682.51% | +1269.71 pp |
| Q3 2013 | 2013-01-31 | −715.64% | +548.19 pp |
| Q2 2013 | 2012-10-31 | −132.62% | +2026.11 pp |
| Q1 2013 | 2012-07-31 | −615.75% | +9146.14 pp |
| Q4 2012 | 2012-04-30 | −1,952.22% | −12312.73 pp |
| Q3 2012 | 2012-01-31 | −1,263.83% | −8845.99 pp |
| Q2 2012 | 2011-10-31 | −2,158.73% | — |
| Q1 2012 | 2011-07-31 | −9,761.90% | — |
| Q3 2011 | 2011-01-31 | 10,360.51% | — |
| Q2 2011 | 2010-10-31 | 7,582.16% | — |
Tenax Therapeutics operating margin trends
Across the available reported history, Tenax Therapeutics's operating margin decreased from −10,452.11% to −30,062.78%, a change of −19610.67 percentage points. The latest reported quarter, Q3 2014, shows −5,807.85%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tenax Therapeutics filings at SEC.gov ↗